Blood Cancer Update: New Insights for the Future

 

Related Videos (117)

Edward A. Stadtmauer, MD, Section Chief for Hematological Malignancies at the Abramson Cancer Center offers a comprehensive update on recent advances in the diagnosis, treatment and clinical research for the hematologic malignancies, including multiple myeloma, the acute and chronic myeloid and lymphocytic leukemias, Hodgkin and non-­Hodgkin lymphoma and mantle cell lymphoma. Dr. Stadtmauer’s discussion includes an overview of clinical research, novel drug therapies-­­including ibrutinib­­-and a review of integrated mutational profiling and its value.

 

Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®